4.3 Article

Spontaneous hypoglycemia: diagnostic evaluation and management

期刊

ENDOCRINE
卷 53, 期 1, 页码 47-57

出版社

SPRINGER
DOI: 10.1007/s12020-016-0902-0

关键词

Spontaneous hypoglycemia; Insulinoma; Non-insulinoma pancreatogenous hypoglycemia syndrome; Insulin autoimmune syndrome; Postprandial hypoglycemia (reactive hypoglycemia); Non-islet cell tumor hypoglycemia; 72-Hour supervised fast test

向作者/读者索取更多资源

Spontaneous hypoglycemia is a puzzling clinical problem and an important reason for referral to endocrinologists. Several clinical conditions such as insulinomas, non-insulinoma pancreatogenous hypoglycemia syndrome, insulin autoimmune syndrome, postprandial hypoglycemia (reactive hypoglycemia), non-islet cell tumor hypoglycemia, primary adrenal insufficiency, hypopituitarism, and critical illness can be associated with spontaneous hypoglycemia. Rarely, in patients with mental health issues, factious hypoglycemia from extrinsic insulin use or ingestion of oral hypoglycemic agents can obfuscate the clinical picture for clinicians trying to identify an organic cause. In those presenting with Whipple's triad (symptoms +/- signs of hypoglycemia, low plasma glucose, and resolution symptoms +/- signs after hypoglycemia correction), a 72-h supervised fast test with measurement of plasma insulin, c-peptide, pro-insulin, and beta-hydroxybutyrate levels, coupled with plasma/urine sulphonylurea screen, forms the first step in diagnostic evaluation. A mixed meal test is preferable for those with predominantly postprandial symptoms. Additional non-invasive and/or invasive diagnostic evaluation is necessary if an organic hypoglycemic disorder is suspected. With the aid of a few brief clinical case scenarios, we discuss the diagnostic evaluation and management of spontaneous hypoglycemia through this comprehensive article.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据